Screener
ARS Pharmaceuticals, Inc. SPRY Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by ARS Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: ARS Pharmaceuticals, Inc.’s 10-Q, filed May 15, 2026.
- Filed
- May 15, 2026, 6:17 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-225142
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 28,662 | 25,347 |
| Inventories | 8,817 | 8,369 |
| Prepaid expenses and other current assets | 6,788 | 6,194 |
| Total current assets | 245,236 | 284,896 |
| Inventories, noncurrent | 23,221 | 23,053 |
| Property, plant and equipment, net | 2,285 | 2,465 |
| Intangible assets, net | 14,176 | 14,452 |
| Other assets | 2,653 | 2,786 |
Item 1. Financial Statements
FAQ
- What is ARS Pharmaceuticals, Inc.'s total current assets?
- ARS Pharmaceuticals, Inc. (SPRY) reported total current assets of $245.24M in Q1 2026.
- How has ARS Pharmaceuticals, Inc.'s total current assets changed year-over-year?
- ARS Pharmaceuticals, Inc.'s total current assets decreased by 19.3% year-over-year, from $303.86M to $245.24M.
- What is the long-term trend for ARS Pharmaceuticals, Inc.'s total current assets?
- Over 5 years (2020 to 2025), ARS Pharmaceuticals, Inc.'s total current assets has grown at a -6.1% compound annual growth rate (CAGR), from $390.66M to $284.9M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about ARS Pharmaceuticals, Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude